论文部分内容阅读
过去不少医疗单位的细菌检验室把B族溶血性链球菌(GBS)按非A族溶血性链球菌处理。近年来已知GBS是引起围产期及新生儿重症感染中发病率最高的致病菌。美国每年有1万名以上的新生儿罹患本病,其中半数死亡。作为新生儿死亡原因,已超过呼吸窘迫综合征,故受到欧美、日本等国的高度重视。1933年Lacefield将链球菌进行血清学分类,提出了B族溶血性链球菌(GBS)这一名称,1938年Fry首先报告了人的GBS传染病,1961年Hood报告GBS与围产期合并症紧密相关,1964年Eickhoff报
In the past, many medical units of bacteria laboratory B hemolytic streptococcus (GBS) non-A hemolytic streptococcus treatment. In recent years, GBS is known to cause the highest incidence of pathogenic bacteria in perinatal and neonatal severe infections. More than 10,000 newborns in the United States suffer from this disease each year, and half of them die. As a neonatal cause of death, respiratory distress syndrome has been exceeded, so by the United States, Japan and other countries attach great importance. In 1933 Lacefield serologically classified Streptococcus, made the name of Group B hemolytic streptococcus (GBS), 1938 Fry first reported human GBS infection, 1961 Hood report GBS and perinatal complications close Related, 1964 Eickhoff newspaper